Answers are grounded in this paper and cite their sources.
Venous thromboembolism is increasingly recognized as a chronic, systemic disease with a high recurrence rate, necessitating careful management with anticoagulants such as warfarin.
Venous thromboembolism encompasses deep venous thrombosis and pulmonary embolism, which represent different manifestations of the same disease process. Indeed, most patients in whom symptoms of either condition develop will simultaneously have overt or subclinical evidence of the other. Our understanding of the causes and natural history of venous thromboembolism has undergone considerable evolution in recent years, influencing the clinical approach to diagnosis and treatment. It is now recognized that venous thromboembolism is a chronic disease. Almost one third of patients have a recurrence within eight years after the initial event.1 Furthermore, venous thromboembolism is at least in part a systemic . . .
No takes yet. Share an insight, caveat, or question.
Andrew I. Schafer (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: